ClinicalTrialsFinder

Thrombocytopenia Alloimmune Clinical Trials in Changzhou, Jiangsu

1 recruitingChangzhou, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

Thrombocytopenia Alloimmune
Changzhou No.2 People's Hospital9 enrolled1 locationNCT06337474